Ambulatory TAVR: Early Feasibility Experience During the COVID-19 Pandemic

The COVID-19 pandemic has modified practice for patients with symptomatic aortic stenosis and could result in higher mortality rates due to treatment delays. In this clinical case series, 3 patients underwent ambulatory transcatheter aortic valve replacement (TAVR) thanks to patient and entourage wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zouaghi, Oualid, Wintzer-Wehekind, Jérôme, Lienhart, Yves, Abdellaoui, Mohamed, Faurie, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442149/
https://www.ncbi.nlm.nih.gov/pubmed/32864601
http://dx.doi.org/10.1016/j.cjco.2020.08.005
Descripción
Sumario:The COVID-19 pandemic has modified practice for patients with symptomatic aortic stenosis and could result in higher mortality rates due to treatment delays. In this clinical case series, 3 patients underwent ambulatory transcatheter aortic valve replacement (TAVR) thanks to patient and entourage willingness, careful patient selection (including a history of permanent pacemaker placement), and a minimalist procedural approach. No complications occurred during the 30-day follow-up. Performing ambulatory TAVR could reduce the clinical consequences of wait times, minimize exposure to coronavirus contamination, and reduce the use of hospital resources that might be needed for COVID-19 patients. Thanks to a scrupulous minimalist TAVR protocol, ambulatory outpatient management of aortic stenosis was possible in the context of the COVID-19 pandemic.

Ejemplares similares